Electroacupuncture Upregulated Ghrelin in Rats with Functional Dyspepsia via AMPK/TSC2/Rheb-Mediated mTOR Inhibition
Open Access
- 21 December 2019
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 65 (6) , 1689-1699
Abstract
Background Gastrointestinal motility disorder is an important pathological basis for functional dyspepsia (FD). Epigastric ache and discomfort are the main symptoms of FD, and ghrelin deficiency is closely related to the occurrence and development of FD. While electroacupuncture (EA) alleviated the symptoms of FD patients and improved their quality of life, there is a lack of sufficient mechanistic evidence to support these beneficial effects. Methods An in vivo FD model was established in wild-type and mammalian target of rapamycin (mTOR) knockout (−/−) rats. FD rats were subjected to EA with or without mTOR agonists or inhibitors. Gastric emptying and intestinal propulsion were assessed, and pathological changes in the hypothalamus, gastric antrum, and small intestine were examined histologically. In addition, ghrelin expression and AMPK/TSC2/Rheb/mTOR activation were detected by quantitative reverse transcription polymerase chain reaction and western blot. Results EA alone or in combination with mTOR inhibitors improved gastrointestinal function in FD rats by increasing the rates of intestinal propulsion and gastric emptying, and pathological changes in the hypothalamus, gastric antrum, and small intestine were alleviated. This may be related to the significant upregulation of ghrelin expression and the effective activation of the AMPK/TSC2/Rheb/mTOR signaling pathway. Interestingly, EA also improved gastrointestinal function and ghrelin expression in mTOR (−/−) KO FD rats. Conclusion Altering the level of ghrelin by regulating AMPK/TSC2/Rheb-mediated mTOR inhibition is an important way through which EA treats FD. The complex EA-mediated regulatory mechanisms of the brain–gut axis still require further exploration.Keywords
Funding Information
- the 2016 special foundation of Yellow Crane Meritocrat (【2017】2)
This publication has 46 references indexed in Scilit:
- Functional dyspepsia—symptoms, definitions and validity of the Rome III criteriaNature Reviews Gastroenterology & Hepatology, 2013
- cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activityCellular Signalling, 2011
- Epidemiology of Uninvestigated and Functional Dyspepsia in Asia: Facts and FictionJournal of Neurogastroenterology and Motility, 2011
- Ghrelin: A gut hormonal basis of motility regulation and functional dyspepsiaJournal of Gastroenterology and Hepatology, 2011
- Gastric Mammalian Target of Rapamycin Signaling Regulates Ghrelin Production and Food IntakeEndocrinology, 2009
- AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectivesActa Physiologica, 2009
- Relation Among Plasma Ghrelin Level, Gastric Emptying, and Psychologic Condition in Patients With Functional DyspepsiaJournal of Clinical Gastroenterology, 2007
- Hypothalamic mTOR Signaling Regulates Food IntakeScience, 2006
- Association of the Predominant Symptom With Clinical Characteristics and Pathophysiological Mechanisms in Functional DyspepsiaGastroenterology, 2006
- Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patientsScandinavian Journal of Gastroenterology, 2005